Endothelin receptor antagonists vs placebo
Hepatic toxicity mean duration of study 25 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists showed no clear difference in hepatic toxicity mean duration of study 25 weeks compared with placebo (moderate certainty).
1 finding from 1 review
- Endothelin receptor antagonists for pulmonary arterial hypertension 2021 · Cochrane Headline outcomes onlyOR 1.88 [0.91, 3.9]11 studies · 2250 participantsModerate